References
-
Zhu M, Lin KF, Yeung RY, Li RC: Evaluation of the protective effects of Schizandra chinensis of phase I drug metabolism using a
$CCl_4$ intoxication model. J Ethnopharmacol 67; 61-68, 1999 https://doi.org/10.1016/S0378-8741(98)00210-4 - Molokovskii DS, Davydov VV, Tiulenev VV: The action of adaptogenic plant preparations in experimental alloxan diabetes. Probl Endokrinol 35;82-87, 1987
- Jung GT, Ju IO, Choi JS, Hong JS: The antioxidative, antimicrobial and nitrite scavenging effects of Schizandra chinensis RUPRECHT (Omija) seed. Korean J Food Sci Technol 32;928-935, 2000
- Kim OC, Jang HJ: Volatile components of Schizandra chinenesis Bullion. Agric Chem Biotechnol 37;30-36, 1994
- Shoji K, Yasufumi O: Effect of gomicin A on liver generation. Planta Med 58;489-482, 1992 https://doi.org/10.1055/s-2006-961532
- Shoe HJ, Lee MY, Hwang GS: The effect of Scizandra fructus extract on blood constituents of alloxan-induced diabetes rabbits. J Korean Soc Food Nutr 24;658-662, 1995
- Jang EH, Pyo YH, Ahn MS: Antioxidant effect of Omija extracts. Korean J Soc Food Sci 12;372-376, 1996
- Kang KW, Kim YG, Kim CW, Kim SG: The anti-fibrogenic effect of a pharmaceutical composition of [5-(2-pyrazinyl)-4-methyl- 1,2-bithiol-3-thione] (oltipraz) and dimethyl-4,4'-dime thoxy-5, 6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB). Arch Pharm Res 25;655-663, 2002 https://doi.org/10.1007/BF02976940
- Lowenstein CJ, Dinerman JL, Snyder SH: Nitric oxide: a physiologic messenger. Ann Intern Med 120;227-237, 1994 https://doi.org/10.7326/0003-4819-120-3-199402010-00009
- Tsoulfas G, Geller DA: NF-kappaB in transplantation: friend or foe. Transpl Infect Dis 3;212-219, 2001 https://doi.org/10.1034/j.1399-3062.2001.30405.x
- Hobbs AJ, Higgs A, Moncada S: Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol 39;191-220, 1999 https://doi.org/10.1146/annurev.pharmtox.39.1.191
- Shin HM, Kim MH, Kim BH, Jung SH, Kim YS, Park HJ, Hong JT, Min KR, Kim Y: Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-kappaB without affecting IkappaB degradation. FEBS Lett 571;50-54, 2004 https://doi.org/10.1016/j.febslet.2004.06.056
- Yamamoto Y, Gaynor RB: IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem Sci 29;72-79, 2004 https://doi.org/10.1016/j.tibs.2003.12.003
- Kreutzberg GW: Microglia a sensor for pathological events in the CNS. Trends Neurosci 19;312-318, 1996 https://doi.org/10.1016/0166-2236(96)10049-7
- Kim HS, Whang SY, Woo MS, Park JS, Kim WK, Han IO: Sodium butyrate suppresses interferon-gamma, but not lipopolysaccharide- mediated induction of nitric oxide and tumor necrosis factor-alpha in microglia. J Neuroimmunol 151;85-93, 2004 https://doi.org/10.1016/j.jneuroim.2004.02.006
- Meda L, Cassatella MA, Szendrei GI, Otvos LJr, Baron P, Villalba M, Ferrari D, Rossi F: Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374; 647-650, 1995 https://doi.org/10.1038/374647a0
- Selkoe DJ: Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81;741-766, 2001 https://doi.org/10.1152/physrev.2001.81.2.741
- Kim WK, Jang PG, Woo MS, Han IO, Piao HZ, Lee K, Lee H, Joh TH, Kim HS: A new anti-inflammatory agent KL-1037 represses proinflammatory cytokine and inducible nitric oxide synthase (iNOS) gene expression in activated microglia. Neuropharmacology 47;243-252, 2004 https://doi.org/10.1016/j.neuropharm.2004.03.019
- Kang KW, Kim YG, Kim CW, Kim SG. The anti-fibrogenic effect of a pharmaceutical composition of [5-(2-pyrazinyl)-4- methyl-1,2-dithiol-3-thione] (oltipraz) and dimethyl-4,4'-demethoxy- 5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB). Arch Pharm Res 25;655-663, 2004 https://doi.org/10.1007/BF02976940
- Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F: Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol 27;229-237, 1990 https://doi.org/10.1016/0165-5728(90)90073-V
- Bocchini V, Mazzolla R, Barluzzi R, Blasi E, Sick P, Kettenmann H: An immortalized cell line expresses properties of activated microglial cells. J Neurosci Res 31;616-621, 1992 https://doi.org/10.1002/jnr.490310405
- Petrova TV, Akama KT, Van Eldik LJ: Selective modulation of BV-2 microglial activation by prostaglandin E (2). Differential effects on endotoxin-stimulated cytokine induction. J Biol Chem 274;28823-288237, 1999 https://doi.org/10.1074/jbc.274.40.28823
- Kim WK, Jang PG, Woo MS, Han IO, Piao HZ, Lee K, Lee H, Joh TH, Kim HS: A new anti-inflammatory agent KL-1037 represses proinflammatory cytokine and inducible nitric oxide synthase (iNOS) gene expression in activated microglia. Neuropharmacology 47;243-52, 2004 https://doi.org/10.1016/j.neuropharm.2004.03.019
- Min KJ, Pyo HK, Yang MS, Ji KA, Jou I, Joe EH: Gangliosides activate microglia via protein kinase C and NADPH oxidase. Glia 1548;197-206, 2004
- Furge LL, Fields PR, Goode WE, Konwinski RR, Tressler MC, Stevens-Truss R: Oltipraz inhibits inducible nitric oxide synthase in vitro and inhibits nitric oxide production in activated microglial cells. Arch. Biochem Biophys 424;163-170, 2004 https://doi.org/10.1016/j.abb.2004.02.018
- Joo SS, Won TJ, Lee DI: Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2). Arch Pharm Res 27;954-960, 2004 https://doi.org/10.1007/BF02975850